Home/Ona Therapeutics/Jutta Amersdorffer, Dr med, MBA
JA

Jutta Amersdorffer, Dr med, MBA

Chief Medical Officer

Ona Therapeutics

Therapeutic Areas

Ona Therapeutics Pipeline

DrugIndicationPhase
ONA-255Refractory Breast Cancer and Solid TumorsPre-clinical
ONA-389Prevalent Solid TumorsPre-clinical